Drug & supplement interaction

Asarabacca + Lorlatinib

Lorlatinib brand name: Lorbrena.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Asarabacca and Lorlatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Asarabacca and Lorlatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lorlatinib and Asarabacca in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Asarabacca safety at a glance

Asarabacca overall Avoid It is in a plant family linked to toxic aristolochic acid, which can harm the kidneys and cause cancer.
Pregnancy Likely Unsafe When used orally. Asarabacca might act as a menstrual or uterine stimulant; contraindicated. Read the full pregnancy detail
Breastfeeding Avoid Safety has not been established and toxic compounds may pass to the baby, so avoid it.

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lorlatinib and Asarabacca? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Lorlatinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Lorlatinib is filed under 3 classifications — cytochrome p450 3a4 (cyp3a4) inducers, cytochrome p450 3a4 (cyp3a4) substrates, oral drugs. Asarabacca has documented interactions with 1 drug class — the most serious being nephrotoxic drugs (major) — and none of Lorlatinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Asarabacca Does Interact With Other Medications

Asarabacca has 355 major, known drug interactions in our database — Lorlatinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Asarabacca

Covers the 2,830 medications we’ve checked against Asarabacca. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Asarabacca and Lorlatinib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Diarrhea / Vomiting / Nausea Additional detail

    Asarabacca

    “Orally, asarabacca seems to be well tolerated when used appropriately (12). However, large doses may cause nausea and vomiting (12). Severe poisoning has also been reported. Symptoms of poisoning include burning of tongue, gastroenteritis, diarrhea, skin rashes, and partial paralysis (18). Also, asarabacca is commonly contaminated with aristolochic acid, which is nephrotoxic and carcinogenic.”

    Asarabacca · Natural Medicines adverse-effect record, reported in diarrhea.

    4 sources cited
    1. 12. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
    2. 553. Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98.
    3. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
    4. 6118. Lewis CJ, Alpert S. Letter to health care professionals -- FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. Office of Nutritional Products, Labeling, Dietary Supplements. Center for Food Safety and Appli

    “Orally, large doses of asarabacca may cause nausea and vomiting (12). Severe poisoning has also been reported. Symptoms of poisoning include burning of tongue, gastroenteritis, and diarrhea (18).”

    Asarabacca · Natural Medicines adverse-effect record, reported in diarrhea.

    3 sources cited
    1. 12. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
    2. 553. Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98.
    3. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

Effects for Lorlatinib come from the ADVERSE REACTIONS section of its FDA label; effects for Asarabacca come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 6,977 voluntary FDA FAERS reports for Lorlatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Special populations

Asarabacca in Pregnancy & Breastfeeding

Pregnancy Likely Unsafe

When used orally. Asarabacca might act as a menstrual or uterine stimulant; contraindicated.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Everything else you take

See Every Supplement That Interacts With Lorlatinib

This page covers Asarabacca only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lorlatinib page lists 153 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 110 moderate · 40 minor.

From our pharmacist’s overview on the Lorlatinib page

“Lorlatinib (Lorbrena) treats ALK-positive lung cancer, and keeping its blood level steady is central to keeping the cancer controlled, so I treat this list with genuine vigilance. Nearly all 153 interactions on file run through CYP3A4, the enzyme that clears the drug.”

Reviewed by 2 · Jul 18, 2026

Open the Lorlatinib interaction page

One more smart check

Taking Asarabacca as Part of a Dietary Supplement Product? Check It for Interactions

We hold 2 real supplement products containing Asarabacca, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Asarabacca. Even though Asarabacca itself has no known interaction with Lorlatinib, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Asarabacca and Lorlatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Asarabacca
Top half

#587 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lorlatinib
Steady interest

#1,780 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Asarabacca reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Asarabacca and Lorlatinib records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Asarabacca

What is Asarabacca?

Asarabacca
  • Sinus and nasal congestion
  • Coughs and bronchial complaints
  • Inducing sweating
  • Inducing vomiting (emetic)
  • Digestive upset

Asarabacca is a European woodland plant traditionally used to clear the nose, cause sweating, or trigger vomiting, but it is rarely used today. It belongs to a plant family that often contains aristolochic acid, a substance the FDA considers unsafe because it can cause serious kidney damage and cancer, so we do not recommend using it.

Asarum europaeum · Aristolochiaceae · Rhizome (root) and leaves · Dried herb, powder, tincture, traditional snuff

An interaction check asks whether these two react with each other — it does not ask whether Asarabacca is a good idea for someone in your situation. Here is what our Asarabacca record says about it on its own.

Asarabacca: dosing

There is no established safe or standardized dose for Asarabacca, and because of its toxicity, no dose can be recommended. Older herbal texts list traditional amounts for use as a snuff or emetic, but these do not account for the serious risks now understood.We advise not using this herb at all.

From our Asarabacca monograph — the full record covers uses, side effects and every documented interaction.

Read the full Asarabacca monograph & all interactions
Medication

About Lorlatinib

What Is Lorlatinib Used For?

Brand name: Lorbrena

Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment.

Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Most-Reported Side Effects for Lorlatinib

From FAERS, the FDA’s public side-effect reporting system (6,977 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Neoplasm progression 621 reports
Hallucination 404 reports
Weight increased 399 reports
Blood cholesterol increased 348 reports
Dyspnea 270 reports
See full Lorlatinib drug information
Keep checking

Other Drugs & Asarabacca

Browse every other medication we’ve checked against Asarabacca — both the ones with a known interaction and the ones without. Select any drug for the full detail.

355Major
0Moderate
0Minor
2,474No known interaction
Major

355 interactions

Showing 60 of 355 major interactions — see all 355 on the Asarabacca page.

No interaction 2,474 drugs checked — show the list
Evidence & sources

Asarabacca References

The 4 references that drive our Asarabacca monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
  2. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  3. Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98.
  4. Lewis CJ, Alpert S. Letter to health care professionals -- FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. Office of Nutritional Products, Labeling, Dietary Supplements. Center for Food Safety and Appli

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Asarabacca and Lorlatinib Together: Common Questions

Is it safe to take Asarabacca with Lorlatinib?
We do not list a known interaction between Asarabacca and Lorlatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Asarabacca and Lorlatinib have any of the same side effects?
Yes — our sources link each of them separately to 3 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Asarabacca and Lorlatinib combination checked?
Interactions in our licensed database are recorded against drug classes. Lorlatinib is filed under 3 classifications, and Asarabacca has documented interactions with 1 drug class — none of Lorlatinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Asarabacca interact with any other medications?
Yes. Asarabacca has 355 documented drug interactions in our database — Lorlatinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Lorlatinib interact with any supplements?
Yes. Lorlatinib has documented interactions with 153 supplements in our database — Asarabacca is not one of them. The Lorlatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Lorlatinib and Asarabacca?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.